ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO358

The Impact of Sirtuin 3 in Renal Tubular Cell Apoptosis under Diabetic Conditions

Session Information

Category: Cell Biology

  • 201 Cell Signaling, Oxidative Stress

Authors

  • Wu, Meiyan, College of Medicine, Severance Biomedical Science Institute, Brain Korea 21 PLUS, Yonsei University, Seoul, Korea (the Republic of)
  • Nam, Boyoung, College of Medicine, Severance Biomedical Science Institute, Brain Korea 21 PLUS, Yonsei University, Seoul, Korea (the Republic of)
  • Kang, Sukyung, College of Medicine, Severance Biomedical Science Institute, Brain Korea 21 PLUS, Yonsei University, Seoul, Korea (the Republic of)
  • Yoo, Tae-Hyun, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Korea (the Republic of)
Background

Reactive oxygen species (ROS) play roles in kidney diseases including diabetic nephropathy (DN). Central to tubular injury is mitochondrial dysregulation resulting in ROS overproduction. The role of mitochondrial sirtuins (SIRTs) has been reported to be implicated in numerous ROS-mediated diseases. Since SIRT3 is mainly localized in the mitochondria and regulates mitochondrial function via deacetylation of mitochondrial proteins, SIRT3 has been suggested to be involved in the pathogenesis of kidney diseases. However, the impact of SIRT3 on tubular cell apoptosis under diabetic conditions has never been elucidated.

Methods

In vitro, rat proximal tubular epithelial cells (NRK-52Es) were cultured in DMEM media containing 5.6 mM glucose (normal glucose, NG) or NG + TGF-β1 (10 ng/ml) with or without plasmid SIRT3 transfection. After 48 hours, cells were harvested and mitochondrial fraction was isolated. In vivo, 12 C57BL/6 mice were intraperitoneally injected with saline (Control, C) (N=6) or STZ (50 mg/kg/d) for 5 consecutive days (Diabetes, DM) (N=6), and were sacrificed after 6 weeks. The protein expression of SIRT3, MnSOD, and apoptosis-related proteins (Bax, Bcl-2, cleaved-caspase 3, cytochrome C, and p53) were determined by western blot analysis. Immunofluorescent staining for SIRT3 and Mitotracker staining were also performed with cultured cells, TUNEL assay was conducted with mice renal tissues.

Results

Compared to NG cells, the protein expression of mitochondrial SIRT3 was significantly decreased in TGF-β1-stimulated renal tubular cells, while SIRT3 protein expression in the cytoplasm was comparable between the two groups. Bax, cleaved-caspase 3, and p53 protein expression were significantly increased, whereas the protein expression of Bcl2, MnSOD, and cytochrome C were significantly decreased in tubular cells exposed to TGF-β1. In contrast, transfection with plasmid SIRT3 significantly abrogated the changes in apoptosis-related protein expression in TGF-β1-stimulated cells. A significant decrease in SIRT3 expression was also demonstrated in the kidney of DM mice compared to the C kidney along with a significant increase in TUNEL-positive tubular epithelial cells in the DM kidney.

Conclusion

These results suggest that SIRT3 plays a protective role in tubular injury under diabetic conditions and that SIRT3 can be a promising therapeutic target in patients with DN.